Alnylam Pharmaceuticals Inc (ALNY) revenue is $1.25B
Alnylam Pharmaceuticals Inc (ALNY) revenue is $1.25B as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full ALNY research page for quote, filings, and the rest of the model. This satellite exists so “Alnylam Pharmaceuticals Inc revenue” can rank with the actual number, then send you to /stock/alny.